You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Mallinckrodt
AstraZeneca
McKinsey
Dow

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Alvocidib

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Alvocidib?

Alvocidib is an investigational drug.

There have been 63 clinical trials for Alvocidib. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 1997.

The most common disease conditions in clinical trials are Leukemia, Leukemia, Myeloid, Acute, and Leukemia, Myeloid. The leading clinical trial sponsors are National Cancer Institute (NCI), Tolero Pharmaceuticals, Inc., and Memorial Sloan Kettering Cancer Center.

Recent Clinical Trials for Alvocidib
TitleSponsorPhase
Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination TherapyTolero Pharmaceuticals, Inc.Phase 2
Phase I, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid TumorsTolero Pharmaceuticals, Inc.Phase 1
A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid LeukemiaTolero Pharmaceuticals, Inc.Phase 1

See all Alvocidib clinical trials

Clinical Trial Summary for Alvocidib

Top disease conditions for Alvocidib
Top clinical trial sponsors for Alvocidib

See all Alvocidib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Mallinckrodt
AstraZeneca
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.